Abakavir/lamivudin Remedica 600 mg/300 mg filmom obložene tablete
Name | Abakavir/lamivudin Remedica 600 mg/300 mg filmom obložene tablete |
---|---|
Former Name | Abakavir/Lamivudin Alpha-Medical 600 mg/300 mg filmom obložene tablete |
Marketing Authorisation Number | HR-H-623446421 |
Active Substance | abakavir lamivudin |
Composition | jedna filmom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina |
Pharmaceutical Form | filmom obložena tableta |
Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-623446421-01] |
Manufacturer | Remedica Ltd., Limassol, Cipar |
Marketing Authorisation Holder | Remedica Ltd., Aharnon Street, Limassol Industrial Estate, Limassol, Cipar |
Marketing Authorisation Date | 07.01.2022 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/21-02/64 |
Registration Number | 381-12-01/154-22-05 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J05AR02 |
Medicinal product marketed in the Croatia | Privremeni prekid opskrbe |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Prezentacija za zdravstvene radnike, verzija 3 |